
Karen Pinilla Alba, MD, discusses the safety findings stages 1 and 2 of the phase II/III PARTNER trial in triple negative and/or germline BRCA-mutated breast cancer.

Your AI-Trained Oncology Knowledge Connection!


Published: December 13th 2019 | Updated: